New guideline endorses active surveillance
Thursday, April 8th, 2010 Posted in watchful waiting | No Comments »In its new guidelines, National Comprehensive Cancer Network (NCCN), an alliance of 21 leading cancer centers across the U.S, recommends active surveillance for men deemed to have "very low risk" prostate cancer and a life expectancy of less than 20 ...
Undetectable PSA level following prostate brachytherapy
Wednesday, April 7th, 2010 Posted in radiation therapy | No Comments »A recent article in the on-line UroToday International Journal suggests that brachytherapy can (and perhaps should) use a higher standard for long-term follow-up. To evaluate clinical success and failure after brachytherapy most centers today use the Phoenix criteria that defines biochemical ...
What prostate treatment is best for quality of life?
Tuesday, April 6th, 2010 Posted in Uncategorized | No Comments »According to a new study, despite the popularity of robot-assisted procedures for prostate cancer, when it comes to men's long-term quality of life, patients with earlier stage cancers generally fare better with non-surgical approaches than with surgery. Prostate patients with earlier ...
Prostate weight does not predict PSA recurrence after radical prostatectomy
Monday, April 5th, 2010 Posted in prostatectomy | No Comments »Previous studies have suggested that man with low prostate weight may be at lower risk for prostate cancer recurrence than those with heavier prostates. Researchers at Indiana University School of Medicine suggest in a careful pathological study of 431 surgically removed prostates, a ...
HIV drugs may inhibit retrovirus linked to prostate cancer
Saturday, April 3rd, 2010 Posted in prostate cancer | No Comments »A new study from University of Utah and Emory University/Veterans Affair Medical Center (VA) researchers suggests that certain drugs used to fight HIV also inhibit a retrovirus recently linked to prostate cancer and chronic fatigue syndrome (CFS), Researchers say that study ...
VARI study could improve treatments for prostate cancer
Friday, April 2nd, 2010 Posted in prostate cancer | No Comments »Scientists at Van Andel Research Institute (VARI) have determined how two proteins required for the initiation and development of prostate cancer interact at the molecular level, which could lead to improved treatments for the disease. One of the proteins, androgen receptor, ...
Variation in prostate cancer mortality rates in England
Thursday, April 1st, 2010 Posted in prostate cancer | No Comments »A today report in the Daily Telegraph suggests there is significant variation is prostate cancer mortality rates across England. According to this report, in a former industrial town in the north of the country, built on coal mining and glassmaking during ...